Cutaneous leishmaniasis : skin barrier properties and drug delivery strategies
Cutaneous leishmaniasis (CL) is a parasitic disease caused by several species of the protozoan parasite Leishmania and affects approximately 10 million people worldwide. The drugs currently available such as miltefosine, amphotericin B and pentavalent antimonials, are limited by high cost, considera...
| Main Author: | |
|---|---|
| Published: |
University College London (University of London)
2015
|
| Subjects: | |
| Online Access: | https://ethos.bl.uk/OrderDetails.do?uin=uk.bl.ethos.763043 |